BMC microbiology · 2025
Indole compounds produced by gut microbiota after metabolizing tryptophan improve dysmotility in sepsis via the AHR-TRPA1 axis in enteric nerves.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Jintao, Li Ziang, Jin Tong, Zhang Wanglin, Shi Hongwei, Wang Kanlirong, Qi Jiayi, Sun Liqun
Аннотация
BACKGROUND: Sepsis represents a major global health challenge, and the resulting impaired intestinal motility can lead to numerous adverse outcomes. Indole compounds produced by gut microbiota after metabolizing tryptophan may improve sepsis-induced intestinal dysmotility, though the underlying mechanism remains unclear. Here, we explored the role of 6-formylindolo[3,2-b]carbazole (FICZ), a gut-derived metabolite of tryptophan, in improving dysmotility in sepsis. We found that FICZ-activated aryl hydrocarbon receptor (AHR) on the Enteric Nervous System (ENS) may represent a future therapeutic target for treating dysmotility in sepsis.
METHODS: Five days post-fertilization (5dpf) zebrafish underwent intraperitoneal microinjection of Escherichia coli to induce sepsis. Subsequently, zebrafish were treated with varying concentrations of FICZ and Tol-huc-AHR1a overexpression plasmids. Primary methodologies included micro-filming for intestinal motility observation, immunofluorescence for detecting intestinal motility function-related indicators, and PCR for gene-level analysis. Key endpoints included intestinal peristalsis frequency, neutrophil infiltration, smooth muscle contractility, NO levels, and expression levels of AHR1a, AHR2, TRPA1b, and relevant inflammatory genes.
RESULTS: In septic zebrafish, FICZ reduced intestinal neutrophil infiltration, restored intestinal smooth muscle strength, increased intestinal peristalsis frequency, and enhanced the expression of intestinal AHR1a, AHR2, and transient receptor potential ankyrin 1b(TRPA1b) genes. Overexpression of the AHR1a gene in septic zebrafish reduced the production of the inhibitory neurotransmitter NO by restoring TRPA1b expression in the intestine, thereby restoring intestinal motility. It also restored the low expression level of inflammatory genes in immunocompromised septic zebrafish.
CONCLUSION: The gut microbial metabolite indole improved sepsis-induced intestinal dysmotility via the AHR-TRPA1 axis. AHR may be a future therapeutic target for treating the immunosuppressive state associated with sepsis.
METHODS: Five days post-fertilization (5dpf) zebrafish underwent intraperitoneal microinjection of Escherichia coli to induce sepsis. Subsequently, zebrafish were treated with varying concentrations of FICZ and Tol-huc-AHR1a overexpression plasmids. Primary methodologies included micro-filming for intestinal motility observation, immunofluorescence for detecting intestinal motility function-related indicators, and PCR for gene-level analysis. Key endpoints included intestinal peristalsis frequency, neutrophil infiltration, smooth muscle contractility, NO levels, and expression levels of AHR1a, AHR2, TRPA1b, and relevant inflammatory genes.
RESULTS: In septic zebrafish, FICZ reduced intestinal neutrophil infiltration, restored intestinal smooth muscle strength, increased intestinal peristalsis frequency, and enhanced the expression of intestinal AHR1a, AHR2, and transient receptor potential ankyrin 1b(TRPA1b) genes. Overexpression of the AHR1a gene in septic zebrafish reduced the production of the inhibitory neurotransmitter NO by restoring TRPA1b expression in the intestine, thereby restoring intestinal motility. It also restored the low expression level of inflammatory genes in immunocompromised septic zebrafish.
CONCLUSION: The gut microbial metabolite indole improved sepsis-induced intestinal dysmotility via the AHR-TRPA1 axis. AHR may be a future therapeutic target for treating the immunosuppressive state associated with sepsis.